Haleon (HLN) Non-Current Assets (2021 - 2025)
Haleon (HLN) posted Non-Current Assets of $36.8 billion for Q4 2025, up 1.59% on a QoQ basis from $36.2 billion in Q4 2024, and up 1.59% year-over-year from $36.2 billion in Q4 2024.
Haleon (HLN) Non-Current Assets (2021 - 2025) Analysis & Trends
Haleon's Non-Current Assets history runs 5 years deep, the most recent figure standing at $36.8 billion for Q4 2025.
- Quarterly Non-Current Assets rose 1.59% year-over-year to $36.8 billion in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $36.8 billion (up 1.59% YoY) and the FY2025 annual result came in at $36.5 billion, up 1.11% from the prior year.
- Non-Current Assets was $36.8 billion for Q4 2025 at Haleon, up from $36.2 billion in the prior quarter.
- Across five years, Non-Current Assets topped out at $39.4 billion in Q4 2021 and bottomed at $35.8 billion in Q4 2023.
- A 5-year average of $37.1 billion and a median of $36.5 billion in 2025 frame the typical range for Non-Current Assets.
- Annual changes were most pronounced in 2022 — Non-Current Assets dropped 8.35% — and 2025, when it gained 1.59%.
- Haleon's Non-Current Assets stood at $39.4 billion in 2021, then fell by 8.35% to $36.1 billion in 2022, then decreased by 0.67% to $35.8 billion in 2023, then climbed by 1.02% to $36.2 billion in 2024, then grew by 1.59% to $36.8 billion in 2025.
- Business Quant data shows HLN's Non-Current Assets at $36.8 billion in Q4 2025, $36.2 billion in Q4 2024, and $36.2 billion in Q2 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 36.78 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 26.33 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 8.68 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 79.20 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 3.84 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 15.70 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 25.92 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 2.47 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 9.64 Bn |
| 10 | Vireo Growth | 10.57 Bn | 10.41 Bn | 59.30 Mn | 670.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 36.78 Bn |
| Dec 31, 2024 | 36.20 Bn |
| Jun 30, 2024 | 36.21 Bn |
| Dec 31, 2023 | 35.83 Bn |
| Jun 30, 2023 | 37.49 Bn |
| Dec 31, 2022 | 36.07 Bn |
| Jun 30, 2022 | 38.54 Bn |
| Dec 31, 2021 | 39.36 Bn |